All PlansCoverageLow impact
Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
Blue Cross & Blue Shield of Mississippi·Endocrinology, Internal Medicine, Family Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy confirms that Chronic Intermittent Intravenous Insulin Therapy (CIIIT) remains classified as investigational and is not covered. The policy was recently updated but maintains the same non-coverage stance that has been in place since 2002.
Action Required
No immediate action required. Billing team should continue to deny coverage for CIIIT procedures using HCPCS code G9147 as this remains investigational. Verify that billing system flags G9147 as non-covered investigational procedure.